Oaktree Capital Group Holdings GP, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

Filing Manager
Oaktree Capital Group Holdings GP, LLC
Reporting Manager
Oaktree Capital Holdings, LLC
Security
BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
BTAI
Shares outstanding
6,235,531 shares
Disclosed Ownership
170,230 shares
Ownership
2.7%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:15:15 UTC
Date of event
31 Mar 2025
Previous filing
18 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oaktree Fund Advisors, LLC 0.83% 51,429 0 51,429 /s/ Henry Orren Henry Orren, Authorized Signatory
Oaktree Capital Management LP 1.9% 118,801 0 118,801 /s/ Henry Orren Henry Orren, Authorized Signatory
Oaktree Capital Holdings, LLC 2.7% 170,230 0 170,230 /s/ Henry Orren Henry Orren, Authorized Signatory
Oaktree Capital Group Holdings GP, LLC 2.7% 170,230 0 170,230 /s/ Henry Orren Henry Orren, Authorized Signatory